5 • 644 Ratings
🗓️ 20 November 2018
⏱️ 31 minutes
🧾️ Download transcript
In this episode, we continue to review insulin therapy including dosing-related specifications, dosing adjustments, injection technique, patient counseling pearls, and the concept of a sliding scale.
Click on a timestamp to play from that location
0:00.0 | Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions. |
0:11.0 | This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy. |
0:17.0 | This podcast contains general information for educational purposes only. This is not professional |
0:22.5 | advice and should not be used in lieu of obtaining advice from a qualified health care provider. |
0:27.2 | And now on to the show. |
0:31.1 | Welcome to Helix Talk episode 87. I'm your co-host Dr. Kane. I'm Dr. Schumann. And I'm Dr. |
0:36.3 | Patel. And in this continuing episode of |
0:39.1 | everything you need to know about insulin in one shot, technically two shots, episode 87, |
0:44.7 | we're going to continue our discussion on insulin. If you remember in the last episode, |
0:48.8 | we discussed different types of insulin, how they're available, what should be kept in |
0:53.9 | mind as far as the admin technique go, |
0:56.0 | and what are the different storage specification in this episode? However, we're going to talk |
1:01.1 | about the dosing for both type 1 and type 2 patient. What are the dosing adjustments as we need |
1:06.6 | to titrate the insulin? What are some sliding scale dosing methods criteria to keep in mind, |
1:12.3 | and just the overall education that should go along with initiating insulin therapy. |
1:17.6 | Well, why don't we kick it off with just talking about insulin dosing? And as I understand it, |
1:21.3 | type 1 diabetic patients are going to be a little bit different than type 2 diabetic patients. |
1:25.2 | Correct. Type 1 diabetes patients, again, underlying pathophysiology |
1:29.0 | is insulin resistant, meaning they may still have in the initial years some insulin production. |
1:34.1 | So their needs for the total daily dose of insulin is going to be a little bit different. And the way we |
1:40.1 | start therapy in type 2 patient is a little different too. We don't bombard them with, |
1:44.6 | you know, 24-hour basobolus insulin therapy. We usually start out with basal insulin first. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Sean P. Kane, PharmD, BCPS, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Sean P. Kane, PharmD, BCPS and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.